Canopy Growth Corp

• What Trump's reclassification of pot and CBD could mean for seniors, research and stocks - Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.
• Trump says he's 'strongly' considering reclassifying pot via executive order - Pot stocks fell on Monday as investors took profits following a record-setting session.